Annals of Oncology

Editorials:

David J. Kerr

A word in your ear: the 2004 Annals of Oncology prizes
Ann Oncol 15: 1303-1304; doi:10.1093/annonc/mdh364
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Gajic, R. Herrmann, and M. Salzberg

The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them
Ann Oncol 15: 1305-1309; doi:10.1093/annonc/mdh363
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

A. Zaniboni and R. Labianca

Adjuvant therapy for stage II colon cancer: an elephant in the living room?
Ann Oncol 15: 1310-1318; doi:10.1093/annonc/mdh342
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Pich, L. Chiusa, and R. Navone

Prognostic relevance of cell proliferation in head and neck tumors
Ann Oncol 15: 1319-1329; doi:10.1093/annonc/mdh299
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Gastrointestinal tumors:

G. Folprecht, D. Cunningham, P. Ross, B. Glimelius, F. Di Costanzo, J. Wils, W. Scheithauer, P. Rougier, E. Aranda, H. Hecker, and C.-H. Köhne

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
Ann Oncol 15: 1330-1338; doi:10.1093/annonc/mdh344
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. André, C. Tournigand, O. Rosmorduc, S. Provent, F. Maindrault-Goebel, D. Avenin, F. Selle, F. Paye, L. Hannoun, S. Houry, B. Gayet, J. P. Lotz, A. de Gramont, and C. Louvet

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study
Ann Oncol 15: 1339-1343; doi:10.1093/annonc/mdh351
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Y. S. Hong, S. Y. Song, S. I. Lee, H. C. Chung, S. H. Choi, S. H. Noh, J. N. Park, J. Y. Han, J. H. Kang, K. S. Lee, and J. Y. Cho

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
Ann Oncol 15: 1344-1347; doi:10.1093/annonc/mdh343
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

O. Gentilini, M. Cremonesi, G. Trifirò, M. Ferrari, S. M. Baio, M. Caracciolo, A. Rossi, A. Smeets, V. Galimberti, A. Luini, G. Tosi, and G. Paganelli

Safety of sentinel node biopsy in pregnant patients with breast cancer
Ann Oncol 15: 1348-1351; doi:10.1093/annonc/mdh355
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S.-J. Kim, S.-k. Kim, E. S. Lee, J. Ro, and S. h. Kang

Predictive value of [¹⁸F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
Ann Oncol 15: 1352-1357; doi:10.1093/annonc/mdh345
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Tabernero, M. A. Climent, A. Lluch, J. Albanell, J. B. Vermorken, A. Barnadas, A. Antón, C. Laurent, J. I. Mayordomo, N. Estaun, I. Losa, V. Guillem, J. Garcia-Conde, J. L. Tisaire, and J. Baselga

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
Ann Oncol 15: 1358-1365; doi:10.1093/annonc/mdh349
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. W. Saif, S. F. Leitman, G. Cusack, M. Horne, A. Freifeld, D. Venzon, A. PremKumar, K. H. Cowan, R. E. Gress, J. Zujewski, and C. Kasten-Sportes

Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer
Ann Oncol 15: 1366-1372; doi:10.1093/annonc/mdh347
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Rogozinska-Szczepka, B. Utracka-Hutka, E. Grzybowska, B. Maka, E. Nowicka, A. Smok-Ragankiewicz, H. Zientek, J. Steffen, and A. Wojciechowska-Lacka

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
Ann Oncol 15: 1373-1376; doi:10.1093/annonc/mdh352
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

H. J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, C. Kollmannsberger, S. D. Fossa, N. E. Skakkebaek, R. de Wit, K. Fizazi, J. P. Droz, G. Pizzocaro, G. Daugaard, P. H. M. de Mulder, A. Horwich, T. Oliver, R. Huddart, G. Rosti, L. Paz Ares, O. Pont, J. T. Hartmann, N. Aass, F. Algaba, M. Bamberg, I. Bodrogi, C. Bokemeyer, J. Classen, S. Clemm, S. Culine, M. de Wit, H. G. Derigs, K. P. Dieckmann, M. Flasshove, X. Garcia del Muro, A. Gerl, J. R. Germa-Lluch, M. Hartmann, A. Heidenreich, W. Hoeltl, J. Joffe, W. Jones, G. Kaiser, O. Klepp, S. Kliesch, L. Kisbenedek, K. U. Koehrmann, M. Kuczyk, M. P. Laguna, O. Leiva, V. Loy, M. D. Mason, G. M. Mead, R. P. Mueller, N. Nicolai, G. O. N. Oosterhof, T. Pottek, O. Rick, H. Schmidberger, F. Sedlmayer, W. Siegert, U. Studer, S. Tjulandin, H. von der Maase, P. Walz, S. Weinknecht, L. Weissbach, E. Winter, and C. Wittekind

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Ann Oncol 15: 1377-1399; doi:10.1093/annonc/mdh301
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. R. van Dijk, E. W. Steyerberg, S. P. Stenning, and J. D. F. Habbema

Identifying subgroups among poor prognosis patients with nonseminomatous germ cell cancer by tree modelling: a validation study
Ann Oncol 15: 1400-1405; doi:10.1093/annonc/mdh350
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

E. Andreopoulou, P. J. Ross, M. E. R. O'Brien, H. E. R. Ford, K. Priest, T. Eisen, A. Norton, S. Ashley, and I. E. Smith

The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma
Ann Oncol 15: 1406-1412; doi:10.1093/annonc/mdh356
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

S. Rao, D. Watkins, D. Cunningham, D. Dunlop, P. Johnson, P. Selby, B. W. Hancock, C. Fegan, D. Culligan, S. Schey, T. C. M. Morris, T. Lissitchkov, J. W. Oliver, and J. T. Holmlund

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma
Ann Oncol 15: 1413-1418; doi:10.1093/annonc/mdh359
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. Bertz, R. Zeiser, W. Lange, S. Fetscher, C. F. Waller, and J. Finke

Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index
Ann Oncol 15: 1419-1424; doi:10.1093/annonc/mdh353
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

F. Levi, F. Lucchini, E. Negri, W. Zatonski, P. Boyle, and C. La Vecchia

Trends in cancer mortality in the European Union and accession countries, 1980–2000
Ann Oncol 15: 1425-1431; doi:10.1093/annonc/mdh346
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

S. Yamamoto, Y. Tomita, Y. Hoshida, S. Toyosawa, H. Inohara, M. Kishino, M. Kogo, M. Nakazawa, S. Murakami, N. Iizuka, S. Kidogami, M. Monden, T. Kubo, N. Ijuhin, and K. Aozasa

Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
Ann Oncol 15: 1432-1438; doi:10.1093/annonc/mdh354
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Cavaletti, G. Bogliun, L. Marzorati, A. Zincone, M. Piatti, N. Colombo, D. Franchi, M. T. La Presa, A. Lissoni, A. Buda, F. Fei, S. Cundari, and C. Zanna

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
Ann Oncol 15: 1439-1442; doi:10.1093/annonc/mdh348
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

G. Apolone and A. Buda

Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?
Ann Oncol 15: 1443-1444; doi:10.1093/annonc/mdh357
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. A. Ross and J. A. Kettels

Reply to the Letter to the Editor on "Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?", by G. Apolone & A. Buda (Ann Oncol 2004; 15: 1443–1444)
Ann Oncol 15: 1444; doi:10.1093/annonc/mdh358
[Extract] [FREE Full Text] [PDF] [Request Permissions]

O. Altundag, K. Altundag, P. Morandi, and M. Gunduz

Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients
Ann Oncol 15: 1444-1445; doi:10.1093/annonc/mdh360
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Eleftheriades, M. Theofilopoulou, N. Eleftheriades, P. Vrizides, and K. Pistevou-Gompaki

Complete disappearance of multiple periorbital xanthelasmata after chemotherapy for primary extragonadal germ-cell mediastinal tumor
Ann Oncol 15: 1445-1446; doi:10.1093/annonc/mdh361
[Extract] [FREE Full Text] [PDF] [Request Permissions]

V. Pitini, P. Bramanti, C. Arrigo, E. Sessa, G. La Gattuta, and C. Amata

Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient
Ann Oncol 15: 1446; doi:10.1093/annonc/mdh362
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.